Results 161 to 170 of about 5,255,084 (312)

Reconstructing enzyme evolution by protein engineering

open access: yesFEBS Letters, EarlyView.
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler   +2 more
wiley   +1 more source

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

open access: yesMolecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce   +11 more
wiley   +1 more source

Proceedings of the 7th Australian Conference on Quality of Life

open access: yes, 2006
The refereed papers from this international conference held at Deakin University in November 2005 are now online. Papers include Robert Cummins on \u27The wellbeing of caregivers\u27, and Peter Kriel on \u27Quality of work life and business ethics\u27 ...

core  

Theory of Peaceful End of Life: Analysis and Evaluation Using the Whall Framework. [PDF]

open access: yesInt J Health Plann Manage
Velasco Yanez RJ   +5 more
europepmc   +1 more source

Large-scale real-life analysis of survival and usage of therapies in multiple myeloma. [PDF]

open access: yesJ Hematol Oncol, 2023
Lopez-Muñoz N   +17 more
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Life Cycle Analysis of Bulk-Handling Equipment (BHE): Identifying Key Strategies for Carbon Footprint Reduction [PDF]

open access: yes
openBulk handling equipments (BHE) are critical to industrial manufacturing processes, especially in the processing of large amount of bulk materials in the construction and mining industries.
DUKULY, JANNEH VENICIA
core  

Home - About - Disclaimer - Privacy